Document is current
Any future updates will be listed below
-
Authors
Sevilla, J. P. https://orcid.org/0000-0001-9807-657X
Tortorice, Daniel
Kantor, David
Regan, John
Meszaros, Kinga H. https://orcid.org/0000-0003-1010-2409
Beck, Ekkehard C. https://orcid.org/0000-0002-2022-9190
Begum, Najida
Bloom, David E.
-
Funding
Funding for this research was provided by:
GlaxoSmithKline foundation
- License Information
-
More Information
Article History
Received: 17 January 2023
Accepted: 22 November 2023
First Online: 5 January 2024
Declarations
:
: EB and KM are employed by GSK. EB holds shares in GSK. JS is employed by Data for Decisions, LLC (DFD), which contracted with GSK to fund this research. DT, DK and JR report receiving consulting fees from DFD. Outside of the submitted work, JS reports having received grants and consulting fees from GSK, Pfizer, Merck, Sanofi Pasteur MSD, the World Health Organization, and the Bill and Melinda Gates Foundation (BMGF). JPS is a Research Associate at the Harvard T.H. Chan School of Public Health and as such has received research funding from the BMGF. DT reports receiving personal fees from GSK, Merck and Pfizer, outside the submitted work. DK reports receiving personal fees from GSK, and Pfizer, outside the submitted work. DB reports receiving grants from GSK, during the conduct of the study; grants from GSK, personal fees from Merck Vaccines, grants from Pfizer, grants from Sanofi, outside the submitted work. NB is an external contingent worker for GSK and received funds during the conduct of the study. The authors declare no other financial and non-financial relationships and activities.
